Drug intelligence / Profile preview

D091

Development stage: Unknown
Lead developer: Chong Kun Dang Pharmaceutical

Overview

D091 is an investigational pharmaceutical product under development by Chong Kun Dang Pharmaceutical, a South Korean multinational pharmaceutical company. It is currently being evaluated in a Phase 1 clinical trial to assess its pharmacokinetics and safety in healthy male subjects. Specific details regarding its chemical structure, mechanism of action, or intended therapeutic indications are not publicly available at this early stage of development.

Beyond the preview

Go deeper on D091.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on D091.

Explore the full profile